| Serial Number | 98027963 |
| Word Mark | ALACRIS CMTA |
| Filing Date | Monday, June 5, 2023 |
| Status | 814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, July 20, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 9, 2024 |
| Goods and Services | Analysis of human tissues for medical research; Research laboratory services in the field of cancer diagnostics; Scientific research for medical purposes in the area of cancerous diseases; Medical research laboratory services; Scientific investigations for medical purposes; Providing scientific information in the field of medical disorders and their treatment |
| Goods and Services | Advisory services relating to medical problems; Advisory services relating to medical services; Medical analysis of human serum for medical treatment purposes provided by medical laboratories; Medical analysis of human tissues for medical treatment purposes provided by medical laboratories; Breast cancer screening services; Bowel cancer screening services; Cervical cancer screening services; Collection and preservation of human blood; Compilation of medical reports, namely, providing medical information to patients in the form of reports in the field of molecular tumor analysis; Conducting of medical examinations; Health clinic services, namely, medical; Genetic testing for medical purposes; DNA screening for medical purposes; Immunodetection services for medical purposes; Lung cancer screening services; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Medical care and analysis services relating to patient treatment; Medical counseling; Medical diagnostic services; Medical screening; Medical services in the field of oncology; Medical services for the treatment of skin cancer; Medical services for the diagnosis of conditions of the human body; Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; Medical laboratory services for the analysis of blood samples taken from patients for diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Providing cancer screening services; Prostate cancer screening services; Preparation of reports providing medical information to patients relating to medical matters in the field of cancer diagnosis; Public health counseling; Provision of medical services; RNA or DNA analysis for cancer diagnosis and prognosis; Services for the testing of blood for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of sera for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of urine for diagnostic and treatment purposes provided by medical laboratories; Testicular cancer screening services; Next generation sequencing of tumor and control samples for diagnostic and treatment purposes provided by medical laboratories; Bioinformatic analysis of next generation sequencing data for pan-cancer diagnostics, provided by medical laboratories |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 9, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, May 31, 2023 |
| First Use In Commerce Date | Tuesday, December 31, 2024 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 9, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Wednesday, May 31, 2023 |
| First Use In Commerce Date | Tuesday, December 31, 2024 |
| Party Name | Alacris Theranostics GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Berlin 12489 DE |
| Party Name | Alacris Theranostics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Berlin 12489 DE |
| Event Date | Event Description |
| Thursday, June 8, 2023 | NEW APPLICATION ENTERED |
| Sunday, July 9, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 26, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, March 5, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 5, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 30, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 19, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 9, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 3, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 25, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 25, 2025 | SOU EXTENSION 1 FILED |
| Tuesday, February 25, 2025 | SOU EXTENSION 1 GRANTED |
| Wednesday, February 26, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 21, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, February 26, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, August 21, 2025 | USE AMENDMENT FILED |
| Friday, February 27, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, March 2, 2026 | SU - NON-FINAL ACTION - WRITTEN |
| Monday, March 2, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 2, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 2, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, June 2, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, June 30, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Tuesday, June 30, 2026 | WITHDRAWAL OF ATTORNEY GRANTED |
| Thursday, July 16, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 20, 2026 | ASSIGNED TO LIE |
| Monday, July 20, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 20, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |